Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization

被引:33
|
作者
Sawyer, Andrew J. [1 ]
Kyriakides, Themis R. [1 ,2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Pathol, 310 Cedar St LH 108, New Haven, CT 06520 USA
[2] Yale Univ, Dept Biomed Engn, New Haven, CT USA
[3] Yale Univ, Vasc Biol & Therapeut Program, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
Extracellular matrix; Matricellular; Cell-matrix interactions; Angiogenesis; Fibrosis; TISSUE GROWTH-FACTOR; ANGIOGENESIS INHIBITOR ABT-510; MONOCLONAL-ANTIBODY; 81C6; TENASCIN-C LEVELS; BREAST-CANCER CELLS; FOREIGN-BODY REACTION; TUMOR-GROWTH; PHASE-I; MATRIX PROTEIN; MALIGNANT GLIOMA;
D O I
10.1016/j.addr.2015.12.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Extracellular matrix is composed of a complex array of molecules that together provide structural and functional support to cells. These properties are mainly mediated by the activity of collagenous and elastic fibers, proteoglycans, and proteins such as fibronectin and laminin. ECM composition is tissue-specific and could include matricellular proteins whose primary role is to modulate cell-matrix interactions. In adults, matricellular proteins are primarily expressed during injury, inflammation and disease. Particularly, they are closely associated with the progression and prognosis of cardiovascular and fibrotic diseases, and cancer. This review aims to provide an overview of the potential use of matricellular proteins in drug delivery including the generation of therapeutic agents based on the properties and structures of these proteins as well as their utility as biomarkers for specific diseases. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:56 / 68
页数:13
相关论文
共 50 条
  • [41] Editorial: Matricellular Receptors As Potential Targets in Anti-Cancer Therapeutic Strategies
    Emonard, Herve
    Duca, Laurent
    Dedieu, Stephane
    [J]. FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [42] A recent development of new therapeutic agents and novel drug targets for cancer treatment
    Kifle, Zemene Demelash
    Tadele, Meklit
    Alemu, Eyerusalem
    Gedamu, Tadele
    Ayele, Akeberegn Gorems
    [J]. SAGE OPEN MEDICINE, 2021, 9
  • [43] Engineered therapeutic proteins for sustained-release drug delivery systems
    Nguyen, Thoa Thi Kim
    Pham, Khang-Yen
    Yook, Simmyung
    [J]. ACTA BIOMATERIALIA, 2023, 171 : 131 - 154
  • [44] Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation
    Broichhausen, Christiane
    Riquelme, Paloma
    Geissler, Edward K.
    Hutchinson, James A.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2012, 17 (04) : 332 - 342
  • [45] Phogen targets drug delivery - Using HSV to carry therapeutic molecules into cells
    Fox, S
    [J]. GENETIC ENGINEERING NEWS, 1998, 18 (19): : 22 - +
  • [46] Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients
    Kesikli, S. Altug
    Kilickap, Saadettin
    [J]. PROTEIN AND PEPTIDE LETTERS, 2013, 20 (12): : 1345 - 1359
  • [47] Targeted delivery of therapeutic agents to the heart
    Sahoo, Susmita
    Kariya, Taro
    Ishikawa, Kiyotake
    [J]. NATURE REVIEWS CARDIOLOGY, 2021, 18 (06) : 389 - 399
  • [48] Targeted delivery of therapeutic agents to the heart
    Susmita Sahoo
    Taro Kariya
    Kiyotake Ishikawa
    [J]. Nature Reviews Cardiology, 2021, 18 : 389 - 399
  • [49] Nanostructured DNA for the delivery of therapeutic agents
    Nishikawa, Makiya
    Tan, Mengmeng
    Liao, Wenqing
    Kusamori, Kosuke
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2019, 147 : 29 - 36
  • [50] Principles of transmucosal delivery of therapeutic agents
    Blanchette, J
    Kavimandan, N
    Peppas, NA
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (03) : 142 - 151